28.02.2013 Views

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Cytogenetics</strong> <strong>of</strong> Solid Tumors 439<br />

nomas are difficult to distinguish from oncocytomas and clear cell/granular renal cell carcinomas,<br />

and in such cases, demonstration <strong>of</strong> the typical hypodiploid karyotype can be diagnostic. Extremely<br />

hypodiploid karyotypes, particularly those with chromosome counts less than 40, are uncommon in<br />

solid tumors generally, and the characteristic group <strong>of</strong> monosomies found in chromophobe cell carcinomas<br />

has not been described in other renal cell cancer histologies.<br />

Papillary Renal Carcinomas<br />

Approximately 10% <strong>of</strong> all renal carcinomas are papillary, and the cytogenetic pr<strong>of</strong>iles for papillary<br />

renal cell carcinomas are distinctive. <strong>The</strong> differential diagnosis <strong>of</strong> papillary renal carcinoma can<br />

be challenging, particularly with respect to distinction from benign renal adenoma or from clear cell<br />

carcinoma. Benign renal adenomas are common tumors that are <strong>of</strong>ten discovered incidentally by<br />

radiography, angiography, or at autopsy. It has been proposed that papillary renal neoplasms smaller<br />

than 3 cm be classified as benign adenomas, whereas those larger than 3 cm should be classified as<br />

carcinomas. However, size alone does not permit accurate estimation <strong>of</strong> malignant potential. Distinction<br />

between adenoma and carcinoma is further confounded by the observation that kidneys involved<br />

by papillary renal cell carcinoma <strong>of</strong>ten contain papillary renal adenomas, and the suspicion that papillary<br />

renal cell carcinomas arise from the adenomas has been reinforced by cytogenetic studies.<br />

Renal adenomas and papillary carcinomas contain a similar core group <strong>of</strong> chromosome aberrations (–Y,<br />

+7, +17), but these are generally the only cytogenetic aberrations seen in the adenomas (150–152),<br />

whereas papillary carcinomas are apt to have acquired several additional aberrations (153). Hence,<br />

cytogenetic studies indicate a continuum <strong>of</strong> chromosome aberrations in papillary renal cell tumors,<br />

with gain <strong>of</strong> chromosomes 7 and 17 contributing to the early phases <strong>of</strong> nonmalignant neoplastic<br />

progression. Kovacs et al. recommend that renal papillary tumors with isolated trisomies 7 and 17<br />

(with or without loss <strong>of</strong> a sex chromosome) be classified as papillary renal cell adenomas, irrespective<br />

<strong>of</strong> size (150). <strong>The</strong> same investigators recommend that papillary renal cell tumors with complex<br />

karyotypic aberrations be classified as carcinomas, even when small in size. However, published<br />

studies provide little or no clinical follow-up data for these cytogenetic subgroups, and it is not yet<br />

known whether karyotypic complexity predicts patient outcome.<br />

<strong>The</strong> cytogenetic pr<strong>of</strong>ile can be useful in resolving a differential diagnosis <strong>of</strong> papillary versus clear<br />

cell/granular renal cell carcinoma. Most papillary renal cell carcinomas contain some nonpapillary<br />

components, and arbitrary cut<strong>of</strong>fs are used to define the minimal percentage <strong>of</strong> papillary components<br />

required for diagnosis as true papillary renal cell carcinoma. Reliable distinction between papillary<br />

and nonpapillary renal cell carcinoma is important clinically because papillary carcinomas appear to<br />

have a better prognosis, stage for stage, than do nonpapillary carcinomas (154). As discussed earlier,<br />

the most frequent cytogenetic aberrations in papillary renal cell carcinomas include trisomies <strong>of</strong> chromosomes<br />

7, 16, and 17, and loss <strong>of</strong> the Y chromosome; each <strong>of</strong> these aberrations is found in at least<br />

50% <strong>of</strong> papillary renal cell carcinomas (see Fig. 8) (155,156). Additional nonrandom chromosome<br />

aberrations, which are found in 10–50% <strong>of</strong> papillary renal cell carcinomas, include trisomies 3, 8, 12,<br />

and 20 (150). In contrast, clear cell/granular carcinomas rarely have trisomies 16 or 17, but virtually<br />

always have a cytogenetic deletion <strong>of</strong> 3p14–21, which is found in fewer than 10% <strong>of</strong> papillary renal<br />

cell carcinomas (132,134).<br />

Pediatric Renal Cell Carcinomas with Xp11.2 or 6p21 Translocations<br />

Pediatric renal cell carcinomas are uncommon, and they differ from adult cases (which most <strong>of</strong>ten<br />

have clear cell/granular histology) in that they very <strong>of</strong>ten have papillary components. Unlike the<br />

adult papillary renal carcinomas, with their distinctive pr<strong>of</strong>ile <strong>of</strong> chromosomal trisomies, the pediatric<br />

renal carcinomas most <strong>of</strong>ten have translocations involving the X chromosome and chromosome 6.<br />

<strong>The</strong>se translocations are not restricted to pediatric renal carcinomas, but are also found occasionally<br />

in adult papillary carcinomas (157). <strong>The</strong> unifying theme for the pediatric carcinoma translocations is that<br />

they target various members <strong>of</strong> the MiT family <strong>of</strong> transcription factors. <strong>The</strong> most frequent translocation is

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!